Etranacogene Dezaparvovec Shows Sustained Efficacy and Safety in Adult Patients With Severe or Moderately Severe Haemophilia B 3 Years After Administration in the HOPE-B Trial

Details

Language :

English

ISSN :

07209355 and 25675761

Volume :

44

Issue :

1, Number 1 Supplement 1

Database :

Supplemental Index

Journal :

Hämostaseologie

Publication Type :

Periodical

Accession number :

ejs65592877

Full Text :

https://doi.org/10.1055/s-0044-1779108